Page last updated: 2024-08-25

1,2,3,4-tetrahydroquinoline and Colitis

1,2,3,4-tetrahydroquinoline has been researched along with Colitis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
An, LY; Chen, XY; Dai, Z; Di, B; Hou, CZ; Jiang, C; Li, CC; Li, K; Xu, LL; Yang, F; You, QD; You, ST; Zhao, N1

Other Studies

1 other study(ies) available for 1,2,3,4-tetrahydroquinoline and Colitis

ArticleYear
Development of Novel Tetrahydroquinoline Inhibitors of NLRP3 Inflammasome for Potential Treatment of DSS-Induced Mouse Colitis.
    Journal of medicinal chemistry, 2021, 01-14, Volume: 64, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cell Survival; Colitis; Dextran Sulfate; Drug Design; Female; Humans; Inhibitory Concentration 50; Interleukin-1beta; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Monocytes; NLR Family, Pyrin Domain-Containing 3 Protein; Quinolines; Reactive Oxygen Species; Structure-Activity Relationship

2021